ATE483972T1 - Reagenzien und verfahren für krebsprognose und pathologische einstufung - Google Patents
Reagenzien und verfahren für krebsprognose und pathologische einstufungInfo
- Publication number
- ATE483972T1 ATE483972T1 AT07757161T AT07757161T ATE483972T1 AT E483972 T1 ATE483972 T1 AT E483972T1 AT 07757161 T AT07757161 T AT 07757161T AT 07757161 T AT07757161 T AT 07757161T AT E483972 T1 ATE483972 T1 AT E483972T1
- Authority
- AT
- Austria
- Prior art keywords
- reagents
- methods
- cancer prognosis
- pathological grading
- grading
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77456306P | 2006-02-16 | 2006-02-16 | |
| PCT/US2007/062362 WO2007095644A2 (en) | 2006-02-16 | 2007-02-16 | Reagents and methods for cancer prognosis and pathological staging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE483972T1 true ATE483972T1 (de) | 2010-10-15 |
Family
ID=38335516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07757161T ATE483972T1 (de) | 2006-02-16 | 2007-02-16 | Reagenzien und verfahren für krebsprognose und pathologische einstufung |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070207489A1 (de) |
| EP (2) | EP2290361A1 (de) |
| JP (1) | JP5143026B2 (de) |
| CN (2) | CN101384901A (de) |
| AT (1) | ATE483972T1 (de) |
| AU (1) | AU2007214427B2 (de) |
| CA (1) | CA2642542C (de) |
| DE (1) | DE602007009645D1 (de) |
| ES (1) | ES2354181T3 (de) |
| WO (1) | WO2007095644A2 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| US8700335B2 (en) | 2006-05-18 | 2014-04-15 | Caris Mpi, Inc. | System and method for determining individualized medical intervention for a disease state |
| WO2010017822A1 (en) | 2008-08-15 | 2010-02-18 | Visiopharm A/S | A method and a system for determining a target in a biological sample by image analysis |
| US9697582B2 (en) | 2006-11-16 | 2017-07-04 | Visiopharm A/S | Methods for obtaining and analyzing images |
| WO2008143849A2 (en) | 2007-05-14 | 2008-11-27 | Historx, Inc. | Compartment segregation by pixel characterization using image data clustering |
| JP5593221B2 (ja) | 2007-06-15 | 2014-09-17 | ヒストロックス,インコーポレイテッド. | 顕微鏡機器を標準化するための方法およびシステム |
| CA2604317C (en) | 2007-08-06 | 2017-02-28 | Historx, Inc. | Methods and system for validating sample images for quantitative immunoassays |
| CA2596204C (en) | 2007-08-07 | 2019-02-26 | Historx, Inc. | Method and system for determining an optimal dilution of a reagent |
| WO2009029810A1 (en) | 2007-08-31 | 2009-03-05 | Historx, Inc. | Automatic exposure time selection for imaging tissue |
| EP3216874A1 (de) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Verfahren zum stratifizieren und annotieren der behandlungsoptionen eines krebsmedikaments |
| CN102165489B (zh) | 2008-09-16 | 2015-11-25 | 赫斯托克斯公司 | 生物标志物表达的可再现量化 |
| EP2350320A4 (de) * | 2008-11-12 | 2012-11-14 | Caris Life Sciences Luxembourg Holdings | Verfahren und systeme zur verwendung von exosomen zur bestimmung von phänotypen |
| WO2010066252A1 (en) * | 2008-12-09 | 2010-06-17 | Dako Denmark A/S | Method for evaluating pre-treatment |
| US20110306514A1 (en) | 2009-01-14 | 2011-12-15 | United States Department of Health and Human Services | Ratio based biomarkers and methods of use thereof |
| AU2011223789A1 (en) | 2010-03-01 | 2012-09-20 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| RU2012148816A (ru) * | 2010-05-07 | 2014-06-20 | Ф. Хоффманн-Ля Рош Аг | Метод диагностики для определения клеток ex vivo |
| CN101876659B (zh) * | 2010-06-29 | 2013-02-13 | 同济大学 | 用于检测肿瘤的量子点试剂盒 |
| AU2011305445B2 (en) | 2010-09-24 | 2017-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| US9410207B2 (en) * | 2011-12-30 | 2016-08-09 | Abbott Molecular Inc. | Method and compositions for detecting epidermal growth factor receptor variant forms in cancer cells |
| WO2015028974A2 (en) * | 2013-08-30 | 2015-03-05 | Nestec S.A. | Polyp recurrence |
| EP3100054B1 (de) * | 2014-01-28 | 2022-02-23 | Quest Diagnostics Investments Incorporated | Verfahren und zusammensetzungen zum nachweis eines adenoma-adenokarzinom-übergangs bei krebs |
| CN103882139B (zh) * | 2014-04-04 | 2015-06-03 | 上海赛安生物医药科技有限公司 | 一种用于化疗方案选择的多重基因检测试剂盒 |
| US10746740B2 (en) | 2015-01-22 | 2020-08-18 | Konica Minolta, Inc. | Biological substance quantitation method, pathological diagnosis support system, and recording medium storing computer readable program |
| US10517823B1 (en) * | 2016-08-10 | 2019-12-31 | Verily Life Sciences Llc | ROS—responsive liposomes for specific targeting |
| CN107688092B (zh) * | 2017-08-18 | 2020-05-19 | 国家纳米科学中心 | 一种用于癌症患者预后评估的方法 |
| KR102655467B1 (ko) | 2018-02-28 | 2024-04-08 | 니토 보세키 가부시기가이샤 | 고정화 세포 또는 ffpe 조직 절편으로부터 항원성을 증강한 세포핵을 탈리하는 방법 그리고 그것을 위한 항원 부활제 및 키트 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| US6872817B1 (en) | 1986-01-16 | 2005-03-29 | The Regents Of The Univ. Of California | Method of staining target interphase chromosomal DNA |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
| US6326148B1 (en) | 1999-07-12 | 2001-12-04 | The Regents Of The University Of California | Detection of copy number changes in colon cancer |
| WO2001092338A1 (en) * | 2000-06-01 | 2001-12-06 | The Brigham And Women's Hospital, Inc. | Diagnosis of endometrial precancers |
| BR0207290A (pt) * | 2001-02-16 | 2005-06-07 | Immunivest Corp | Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| WO2004000102A2 (en) * | 2002-06-19 | 2003-12-31 | Abgenix, Inc. | Method for predicting response to epidermal growth factor receptor-directed therapy |
| EP1521747B1 (de) * | 2002-07-15 | 2018-09-05 | Symphony Evolution, Inc. | Modulatoren von rezeptor-typ-kinase und anwendungsverfahren |
| AU2003291736A1 (en) * | 2002-11-05 | 2004-06-03 | Cell Signaling Technology, Inc. | Methods and materials for examining pathways associated with glioblastoma progression |
| JP2007506442A (ja) * | 2003-05-30 | 2007-03-22 | ゲノミック ヘルス, インコーポレイテッド | Egfr阻害薬への応答に関する遺伝子発現マーカー |
| DE10345021A1 (de) * | 2003-09-23 | 2005-05-04 | Univ Potsdam | Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen |
| CA2569079A1 (en) * | 2004-06-03 | 2005-12-15 | The Johns Hopkins University | Methods of screening for cell proliferation or neoplastic disorders |
| AU2005250484B2 (en) * | 2004-06-04 | 2011-08-11 | Genentech, Inc. | EGFR mutations |
| CA2583389A1 (en) * | 2004-10-07 | 2006-04-20 | Emory University | Multifunctional nanoparticles conjugates and their use |
| EP2473495A1 (de) * | 2009-09-18 | 2012-07-11 | Almac Discovery Limited | Pharmazeutische verbindungen |
-
2007
- 2007-02-16 ES ES07757161T patent/ES2354181T3/es active Active
- 2007-02-16 AT AT07757161T patent/ATE483972T1/de not_active IP Right Cessation
- 2007-02-16 AU AU2007214427A patent/AU2007214427B2/en not_active Ceased
- 2007-02-16 EP EP10012955A patent/EP2290361A1/de not_active Withdrawn
- 2007-02-16 CN CNA2007800057525A patent/CN101384901A/zh active Pending
- 2007-02-16 JP JP2008555532A patent/JP5143026B2/ja not_active Expired - Fee Related
- 2007-02-16 US US11/707,691 patent/US20070207489A1/en not_active Abandoned
- 2007-02-16 WO PCT/US2007/062362 patent/WO2007095644A2/en not_active Ceased
- 2007-02-16 CN CN201510119060.XA patent/CN104749378A/zh active Pending
- 2007-02-16 DE DE602007009645T patent/DE602007009645D1/de active Active
- 2007-02-16 CA CA2642542A patent/CA2642542C/en not_active Expired - Fee Related
- 2007-02-16 EP EP07757161A patent/EP1984735B1/de not_active Not-in-force
-
2010
- 2010-01-19 US US12/690,008 patent/US20100184099A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070207489A1 (en) | 2007-09-06 |
| CN101384901A (zh) | 2009-03-11 |
| EP1984735A2 (de) | 2008-10-29 |
| JP5143026B2 (ja) | 2013-02-13 |
| US20100184099A1 (en) | 2010-07-22 |
| CA2642542A1 (en) | 2007-08-23 |
| EP2290361A1 (de) | 2011-03-02 |
| DE602007009645D1 (de) | 2010-11-18 |
| WO2007095644A2 (en) | 2007-08-23 |
| EP1984735B1 (de) | 2010-10-06 |
| AU2007214427A1 (en) | 2007-08-23 |
| CN104749378A (zh) | 2015-07-01 |
| AU2007214427B2 (en) | 2011-11-10 |
| ES2354181T3 (es) | 2011-03-10 |
| CA2642542C (en) | 2012-09-25 |
| JP2009527740A (ja) | 2009-07-30 |
| WO2007095644A3 (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602007009645D1 (de) | Reagenzien und verfahren für krebsprognose und pathologische einstufung | |
| DE602006002809D1 (de) | Verfahren zur erkennung eines ovarialkarzinoms | |
| EP2047262A4 (de) | Verfahren zur krebsprognose auf der basis subzellulärer lokalisierung von biomarkern | |
| EP1897940A4 (de) | Zusammensetzung und verfahren zur diagnose von speiseröhrenkrebs sowie der metastasierung von speiseröhrenkrebs | |
| EP1969363A4 (de) | Verfahren und markerkombinationen zum screening auf eine veranlagung zu lungenkrebs | |
| ATE535805T1 (de) | Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen | |
| WO2008154098A3 (en) | Reagents and methods for mirna expression analysis and identification of cancer biomarkers | |
| EP1991701A4 (de) | Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von krebs | |
| DE112006001755A5 (de) | EU/TB-Chelat-basiertes fluoreszenzspektroskopisches Verfahren zum Nachweis von Analyten | |
| DK2211180T3 (da) | Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer | |
| ATE410524T1 (de) | Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen | |
| TWI317811B (de) | ||
| WO2013057581A8 (en) | Composite biomarker for non-invasive screening, diagnosis and prognosis of colorectal cancer | |
| EP1599603A4 (de) | Diagnose- und prognoseverfahren von pankreaskrebs | |
| WO2008097908A3 (en) | Methods of diagnosing and prognosing lung cancer | |
| ATE557276T1 (de) | Spezifisches verfahren zum krebsnachweis | |
| ATE408839T1 (de) | Tumor marker für urothelialen krebs | |
| WO2009085196A8 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk | |
| WO2010009074A3 (en) | Method for predicting and detecting tumor metastasis | |
| WO2007082073A8 (en) | Biomarkers for oral tongue cancer metastasis and extracapsular spread (ecs) | |
| WO2010045318A3 (en) | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type | |
| ATE433158T1 (de) | System und verfahren zur erkennung der breite eines datenbusses | |
| WO2013062261A3 (en) | Newly identified colon cancer marker and diagnostic kit using the same | |
| WO2008104985A3 (en) | Methods for distingushing between lung squamous carcinoma and other non smallcell lung cancers | |
| DE60317606D1 (de) | Marker für Brustkrebsprognose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |